These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 1143508)
1. Proceedings: Metabolic studies with an amylase inhibitor (BAY e 4609). Keup U; Puls W Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R85. PubMed ID: 1143508 [No Abstract] [Full Text] [Related]
2. Acyclic peptide inhibitors of amylases. Pohl N Chem Biol; 2005 Dec; 12(12):1257-8. PubMed ID: 16356842 [TBL] [Abstract][Full Text] [Related]
3. [Proceedings: Insulin, DNA, protein and enzyme concentrations of the pancreas and ciliated border enzymes following short-term and long-term feeding of an alpha-amylase-inhibitor (Bay e 4609)]. Fölsch UR; Grieb N; Caspary WF; Frerichs H; Creutzfeldt W Z Gastroenterol; 1976 Mar; 14 Suppl():250-1. PubMed ID: 960941 [No Abstract] [Full Text] [Related]
4. Impairment of starch absorption by a potent amylase inhibitor. Brugge WR; Rosenfeld MS Am J Gastroenterol; 1987 Aug; 82(8):718-22. PubMed ID: 2440298 [TBL] [Abstract][Full Text] [Related]
5. An evidence-based systematic review of amylase inhibitors by the Natural Standard Research Collaboration. Ulbricht C; Bryan JK; Conquer J; Costa D; Stock T; Tanguay-Colucci S; Weissner W J Diet Suppl; 2010 Mar; 7(1):78-95. PubMed ID: 22435576 [TBL] [Abstract][Full Text] [Related]
6. The nutraceutical role of the Phaseolus vulgaris alpha-amylase inhibitor. Obiro WC; Zhang T; Jiang B Br J Nutr; 2008 Jul; 100(1):1-12. PubMed ID: 18331662 [TBL] [Abstract][Full Text] [Related]
8. [Pathophysiological principles of dose selecting and pharmacodynamic properties of insulin preparations for treatment of diabetes]. Tatoń J; Fedyna M Pol Tyg Lek; 1971 Jan; 26(2):67-71. PubMed ID: 4323213 [No Abstract] [Full Text] [Related]
9. Bean amylase inhibitor and other carbohydrate absorption blockers: effects on diabesity and general health. Preuss HG J Am Coll Nutr; 2009 Jun; 28(3):266-76. PubMed ID: 20150600 [TBL] [Abstract][Full Text] [Related]
10. [Which type of dietary regimen should one choose in type II diabetes? Carbohydrates: nature, quantity and metabolism]. Lean ME Journ Annu Diabetol Hotel Dieu; 1993; ():223-32. PubMed ID: 8392639 [No Abstract] [Full Text] [Related]
11. The dietetic treatment of diabetes mellitus. Mehnert H Horm Metab Res; 1974; Suppl 4():183-6. PubMed ID: 4418893 [No Abstract] [Full Text] [Related]
12. [Dietetic adaptation of pancreatic lipase and amylase in the rat]. Deschodt-Lanckman M; Camus J; Robberecht P; Christophe J Arch Int Physiol Biochim; 1971 Oct; 79(4):829-30. PubMed ID: 4110231 [No Abstract] [Full Text] [Related]
13. [Dietary carbohydrates and their metabolic effects in diabetes, obesity and dyslipidemias]. Guarnieri GF G Clin Med; 1987 Feb; 68(2):109-14. PubMed ID: 3609601 [No Abstract] [Full Text] [Related]
17. Effect of biguanide derivatives (phenformin) on carbohydrate tolerance in "borderline" and asymptomatic ("chemical") diabetes. Results of a 5-year prospective study. Kasperska-Czyzykowa T; Jaskólska K; Gałecki A; Trzaski M; Woy-Wojciechowski J Acta Med Pol; 1986; 27(3-4):141-52. PubMed ID: 3445789 [No Abstract] [Full Text] [Related]
18. [Role of nutrition in the development of type II diabetes mellitus and of glucose intolerance; possibilities for prevention]. Feskens EJ Ned Tijdschr Geneeskd; 1992 Aug; 136(35):1701-6. PubMed ID: 1328898 [No Abstract] [Full Text] [Related]
19. [Interrelationship between protein, fat and carbohydrate metabolism]. Sharmanov TSh; Mukhamedzhanov EK Vopr Pitan; 1982; (4):10-6. PubMed ID: 6750916 [No Abstract] [Full Text] [Related]
20. [Physiological role of dietary carbohydrates in diet of hungarian population. Epidemiological study]. Biro D; Greiner E Vopr Pitan; 1998; (4):11-7. PubMed ID: 9825467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]